Xbrane Biopharma AB (DE:7XB)
BERLIN:7XB
Germany Market

Xbrane Biopharma AB (7XB) Technical Analysis

1 Followers

Summary of all the Indicators

Overall Consensus
Sell
3Bullish
5Neutral
13Bearish
Technical Analysis Consensus
Neutral
2Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Xbrane Biopharma AB’s (7XB) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Xbrane Biopharma AB is a Sell.
Xbrane Biopharma AB’s (7XB) 20-Day exponential moving average is 0.02, while Xbrane Biopharma AB’s (7XB) share price is <€0.1, making it a Sell.
Xbrane Biopharma AB’s (7XB) 50-Day exponential moving average is 0.02, while Xbrane Biopharma AB’s (7XB) share price is <€0.1, making it a Sell.

Xbrane Biopharma AB (7XB) Pivot Points

Jul 25, 2024, 03:56 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.02
0.02
0.02
0.02
0.02
0.02
0.02
Fibonacci
0.02
0.02
0.02
0.02
0.02
0.02
0.02
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Xbrane Biopharma AB (7XB) Moving Averages

Jul 25, 2024, 03:56 PM
Period
Simple
Exponential
MA5
0.02Buy
0.02Sell
MA10
0.02Sell
0.02Sell
MA20
0.02Sell
0.02Sell
MA50
0.02Sell
0.02Sell
MA100
0.03Sell
0.04Sell
MA200
0.07Sell
0.12Sell
Xbrane Biopharma AB’s (7XB) 10-Day exponential moving average is 0.02, while Xbrane Biopharma AB’s (7XB) share price is <€0.1, making it a Sell.
Xbrane Biopharma AB’s (7XB) 100-Day exponential moving average is 0.04, while Xbrane Biopharma AB’s (7XB) share price is <€0.1, making it a Sell.
Xbrane Biopharma AB’s (7XB) stock price is <€0.1 and Xbrane Biopharma AB’s (7XB) 50-day simple moving average is 0.02, creating a Sell signal.
Xbrane Biopharma AB’s (7XB) stock price is <€0.1 and Xbrane Biopharma AB’s (7XB) 100-day simple moving average is 0.03, creating a Sell signal.
Xbrane Biopharma AB’s (7XB) stock price is <€0.1 and Xbrane Biopharma AB’s (7XB) 200-day simple moving average is 0.07, creating a Sell signal.

Xbrane Biopharma AB (7XB) Technical Indicators

Jul 25, 2024, 03:56 PM
Name
Value
Implied Action
RSI (14)
43.37
Neutral
STOCH (9,6)
24.44
Neutral
STOCHRSI (14)
25.00
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
20.70
Neutral
Williams %R
-75.00
Buy
CCI (14)
-64.10
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
22.80
Sell
ROC
0.00
-
Xbrane Biopharma AB’s (7XB) Relative Strength Index (RSI) is 43.37, creating a Neutral signal.
Xbrane Biopharma AB’s (7XB) Trend Strength Indicator (ADX) is 20.70, creating a Neutral signal.
Xbrane Biopharma AB’s (7XB) Commodity Channel Index (CCI) is -64.10, creating a Neutral signal.

FAQ

Is 7XB a Buy, Hold, or Sell?
Based on 7XB’s technical indicators, 7XB is a Sell.
    What is 7XB’s RSI (14)?
    7XB’s RSI (14) is 43.37, which suggests 7XB is a Neutral.
      What is 7XB’s MACD?
      7XB’s MACD is >-0.01, which suggests 7XB is a Sell.
        What is 7XB’s 5-day moving average?
        7XB’s 5-day moving average is 0.02, which suggests 7XB is a Buy.
          What is 7XB’s 20-day moving average?
          7XB 20-day moving average is 0.02, which suggests 7XB is a Sell.
            What is 7XB’s 50-day moving average?
            7XB’s 50-day moving average is 0.02, which suggests 7XB is a Sell.
              What is 7XB’s 200-day moving average?
              7XB’s 200-day moving average is 0.07, which suggests 7XB is a Sell.
                What is 7XB’s Williams % R (14)?
                7XB’s Williams % R (14) is -75.00, which suggests 7XB is a Buy.
                  What is 7XB’s CCI (14)?
                  7XB’s CCI (14) is -64.10, which suggests 7XB is a Neutral.
                    What is the share price of Xbrane Biopharma AB?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis